Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Benztropine mesylate
Cat. No.:
OB0225LY-0168
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Benztropine mesylate is an anticholinergic that is commonly used to regulate the functioning of the nervous system.
Synonym:
Benzotropine mesylate; Benzatropine mesylate; Benztropine methanesulfonate; 132-17-2; 3-Diphenylmethoxytropane mesylate; (1R,3R,5S)-3-(Diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane
CAS No.:
132-17-2
Compound CID:
3246155
Formula:
C21H25NO·CH4SO3
Formula Weight:
403.53
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Benztropine mesylate can be used to inhibit the uptake of dopamine.
Library Information
Targets:
G protein-coupled receptors (GPCRs)
Receptors:
Dopamine receptor; Histamine receptor; mAChR
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-3
Plate Location:
a11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 111.52 mM
Water Max Solubility:
74 mg/mL; 183.4 mM
Ethanol Max Solubility:
75 mg/mL; 185.9 mM
